Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

Clinical trial NCT04797780 · TERMINATED

Trial details

NCT number: NCT04797780
Sponsor: Syros Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2021-02-08
Primary completion: 2024-11-13
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.